Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride‐induced liver fibrosis and hepatic stellate cell activation

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Immunopharmacology

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.intimp.2018.01.029PMID 29414645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pien Tze Huang Gan Bao attenuates carbon tetrachloride-induced hepatocyte apoptosis in rats, associated with suppression of p53 activation and oxidative stress

  2017cited by this paper
• Management strategies for liver fibrosis.

  2017cited by this paper
• Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant?

  2017cited by this paper
• Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism

  2017cited by this paper
• Spermidine Prolongs Lifespan and Prevents Liver Fibrosis and Hepatocellular Carcinoma by Activating MAP1S-Mediated Autophagy.

  2017cited by this paper
• Histopathological evaluation of liver fibrosis and cirrhosis regression

  2017cited by this paper
• Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer

  2017cited by this paper
• Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome

  2017cited by this paper
• Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel

  2017cited by this paper
• Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis

  2017cited by this paper
• Reversal of liver fibrosis: From fiction to reality.

  2017cited by this paper
• Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway.

  2017cited by this paper
• Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease

  2017cited by this paper
• Recent progression in the utilization of autophagy-regulating nature compound as anti-liver fibrosis agents

  2017cited by this paper
• Tetramethylpyrazine attenuates sinusoidal angiogenesis via inhibition of hedgehog signaling in liver fibrosis

  2017cited by this paper
• Exosomes derived from miR‐181‐5p‐modified adipose‐derived mesenchymal stem cells prevent liver fibrosis via autophagy activation

  2017cited by this paper
• Oroxylin A inhibits H2O2-induced oxidative stress in PC12 cells

  2017cited by this paper
• ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis.

  2016cited by this paper
• Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell

  2016cited by this paper
• Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53

  2016cited by this paper
• Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2.

  2016cited by this paper
• Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism.

  2016cited by this paper
• The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.

  2016cited by this paper
• The role of C/EBP-α expression in human liver and liver fibrosis and its relationship with autophagy.

  2015cited by this paper
• Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells

  2015cited by this paper
• Autophagy: A new therapeutic target for liver fibrosis.

  2015cited by this paper
• Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization

  2015cited by this paper
• The update on transcriptional regulation of autophagy in normal and pathologic cells: A novel therapeutic target.

  2015cited by this paper
• PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.

  2014cited by this paper
• Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro.

  2013cited by this paper
• A role for autophagy during hepatic stellate cell activation.

  2012cited by this paper
• Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection.

  2012cited by this paper
• Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

  2012cited by this paper
• Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

  2011cited by this paper

• Autophagic Response of the Liver Cells to Schistosoma mansoni Infection and Praziquantel Treatment

  2025cites this paper
• Engineered Intelligent Microenvironment Responsive Prodrug Conjugates Navigated by Bioinspired Lipoproteins for Reversing Liver Fibrosis

  2025cites this paper
• Chinese Medicine for the Treatment of Liver Cirrhosis: The Mechanism of Cellular Autophagy.

  2025cites this paper
• Dihydroartemisinin: A Promising Therapeutic Agent Against the Hepatitis-to-Hepatocellular Carcinoma Cascade

  2025cites this paper
• Orphan drug uttroside B impedes MASH progression and HCC development in experimental models

  2025cites this paper
• Aldose Reductase Mediated Mitophagy Promotes Epithelial-Mesenchymal Transition of Hepatocytes

  2025influential citation
• First-in-class drug oroxylin A tablets for treating hepatic and gastrointestinal disorders: from preclinical development to clinical research.

  2025cites this paper
• Inhibiting Liver Autophagy and Promoting Hepatocyte Apoptosis by Schistosoma japonicum Infection

  2024cites this paper
• First transcriptome analysis of the venom glands of the scorpion Hottentotta zagrosensis (Scorpions: Buthidae) with focus on venom lipolysis activating peptides

  2024cites this paper
• Research Progress of Chinese Medicine in Treating Chronic Liver Disease by Regulating Autophagy.

  2024cites this paper
• Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

  2024cites this paper
• Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: Molecular Mechanisms and Nanoparticulate Drug Delivery Systems

  2024cites this paper
• The potential of flavonoids in hepatic fibrosis: A comprehensive review.

  2024cites this paper
• Advances in Research on the Effectiveness and Mechanism of Active Ingredients from Traditional Chinese Medicine in Regulating Hepatic Stellate Cells Autophagy Against Hepatic Fibrosis

  2024cites this paper
• Plant‐derived flavonoids are a potential source of drugs for the treatment of liver fibrosis

  2024cites this paper
• Oroxylin A suppress LL-37 generated rosacea-like skin inflammation through the modulation of SIRT3-SOD2-NF-κB signaling pathway.

  2024cites this paper
• Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease

  2023cites this paper
• Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis

  2023cites this paper
• Oroxylin A: Nature's Arsenal Against Liver Fibrosis, Cancer, and Inflammatory Diseases

  2023cites this paper
• Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy

  2023cites this paper
• Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study

  2023cites this paper
• Oroxylin A activates ferritinophagy to induce hepatic stellate cell senescence against hepatic fibrosis by regulating cGAS-STING pathway.

  2023cites this paper
• Oroxylin A relieves intrauterine adhesion in mice through inhibiting macrophage pyroptosis via SIRT3-SOD2-ROS pathway.

  2023cites this paper
• Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle.

  2023cites this paper
• Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis.

  2023cites this paper
• Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less

  2022cites this paper
• Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less

  2022cites this paper
• Natural-Product-Mediated Autophagy in the Treatment of Various Liver Diseases

  2022cites this paper
• Exploring the mechanism of action of Chinese medicine in regulating liver fibrosis based on the alteration of glucose metabolic pathways

  2022cites this paper
• Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis

  2022cites this paper
• Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases

  2022cites this paper
• Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice

  2022cites this paper
• Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives

  2022cites this paper
• Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis

  2022influential citation
• Resolvin D1 attenuates CCl4 Induced Liver Fibrosis by Inhibiting Autophagy-Mediated HSC activation via AKT/mTOR Pathway

  2021cites this paper
• Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα

  2021cites this paper
• Circular RNA Expression Profile in Patients with Lumbar Spinal Stenosis Associated with Hypertrophied Ligamentum Flavum

  2021cites this paper
• Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells

  2021cites this paper
• Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?

  2021cites this paper
• Knockdown of TRIM15 inhibits the activation of hepatic stellate cells

  2021cites this paper
• The role of autophagy in hepatic fibrosis.

  2021cites this paper
• The role of autophagy in hepatic fibrosis

  2021cites this paper
• Ubiquitin pathways regulate the pathogenesis of chronic liver disease.

  2021cites this paper
• Autophagy plays a double-edged sword role in liver diseases

  2021cites this paper
• Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology

  2021cites this paper
• Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα

  2021cites this paper
• BNIP3 relieves the LPS-induced in ammation and apoptosis of chondrocytes by promoting the development of autophagy

  2020cites this paper
• A Radioiodinated Nitroxide Probe with Improved Stability against Bioreduction for In Vivo Detection of Lipid Radicals.

  2020cites this paper
• Extracellular vesicles‐derived miR‐150‐5p secreted by adipose‐derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis

  2020cites this paper
• TGF-β1-induced autophagy activates hepatic stellate cells via the ERK and JNK signaling pathways

  2020cites this paper
• A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids

  2020cites this paper
• Inhibition of miR-155 potentially protects Lipopolysaccharide-induced acute lung injury through the IRF2BP2-NFAT1 pathway.

  2020cites this paper
• Anti-fibrosis potential of pirarubicin via inducing apoptotic and autophagic cell death in rabbit conjunctiva.

  2020cites this paper
• The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis

  2020cites this paper
• BNIP3 decreases the LPS-induced inflammation and apoptosis of chondrocytes by promoting the development of autophagy

  2020cites this paper
• Tβ4 suppresses lincRNA-p21-mediated hepatic apoptosis and fibrosis by inhibiting PI3K-AKT-NF-κB pathway.

  2020cites this paper
• ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis.

  2020cites this paper
• Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.

  2020cites this paper
• Preventive effect of lemon seed flavonoids on carbon tetrachloride-induced liver injury in mice

  2020cites this paper
• LncRNA TUG1 regulates autophagy-mediated endothelial-mesenchymal transition of liver sinusoidal endothelial cells by sponging miR-142-3p.

  2020cites this paper
• Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway.

  2020cites this paper
• Benzoquinone derivatives with antioxidant activity inhibit activated hepatic stellate cells and attenuate liver fibrosis in TAA-induced mice.

  2020cites this paper
• SVIP alleviates CCl4-induced liver fibrosis via activating autophagy and protecting hepatocytes

  2019cites this paper
• Triggering apoptosis by oroxylin A through caspase-8 activation and p62/SQSTM1 proteolysis

  2019cites this paper
• Hepatoprotective effects of an Acer tegmentosum Maxim extract through antioxidant activity and the regulation of autophagy.

  2019cites this paper
• Artesunate protects against surgery-induced knee arthrofibrosis by activating Beclin-1-mediated autophagy via inhibition of mTOR signaling.

  2019cites this paper
• Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells

  2019cites this paper
• α-Lipoic acid modulates liver fibrosis: A cross talk between TGF-β1, autophagy, and apoptosis

  2019cites this paper
• Punicalagin Reversed the Hepatic Injury of Tetrachloromethane by Antioxidation and Enhancement of Autophagy

  2019cites this paper
• Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.

  2019cites this paper
• Oroxylin A regulates the turnover of lipid droplet via downregulating adipose triglyceride lipase (ATGL) in hepatic stellate cells.

  2019cites this paper
• The lncRNA NEAT1/miR-29b/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells.

  2019cites this paper
• Reconstruction and analysis of competitive endogenous RNA network reveals regulatory role of long non-coding RNAs in hepatic fibrosis

  2019cites this paper
• Research progress on the anti-hepatic fibrosis action and mechanism of natural products.

  2019cites this paper
• Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells

  2019cites this paper
• Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice.

  2018cites this paper
• Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy

  2018cites this paper
• Effect of MSE on Activity and Molecular Biology in Rat Induced Liver Injury

  year unknowncites this paper